540 related articles for article (PubMed ID: 34208601)
1. Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer.
Kasprzak A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208601
[TBL] [Abstract][Full Text] [Related]
2. CRNDE, a long non-coding RNA responsive to insulin/IGF signaling, regulates genes involved in central metabolism.
Ellis BC; Graham LD; Molloy PL
Biochim Biophys Acta; 2014 Feb; 1843(2):372-86. PubMed ID: 24184209
[TBL] [Abstract][Full Text] [Related]
3. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
Kasprzak A; Adamek A
Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
[TBL] [Abstract][Full Text] [Related]
4. Kinome Screen Identifies PFKFB3 and Glucose Metabolism as Important Regulators of the Insulin/Insulin-like Growth Factor (IGF)-1 Signaling Pathway.
Trefely S; Khoo PS; Krycer JR; Chaudhuri R; Fazakerley DJ; Parker BL; Sultani G; Lee J; Stephan JP; Torres E; Jung K; Kuijl C; James DE; Junutula JR; Stöckli J
J Biol Chem; 2015 Oct; 290(43):25834-46. PubMed ID: 26342081
[TBL] [Abstract][Full Text] [Related]
5. Autophagy and the Insulin-like Growth Factor (IGF) System in Colonic Cells: Implications for Colorectal Neoplasia.
Kasprzak A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835075
[TBL] [Abstract][Full Text] [Related]
6. New strategies for targeting glucose metabolism-mediated acidosis for colorectal cancer therapy.
Wang G; Wang JJ; Yin PH; Xu K; Wang YZ; Shi F; Gao J; Fu XL
J Cell Physiol; 2018 Jan; 234(1):348-368. PubMed ID: 30069931
[TBL] [Abstract][Full Text] [Related]
7. Fucoidan downregulates insulin-like growth factor-I receptor levels in HT-29 human colon cancer cells.
Kim IH; Nam TJ
Oncol Rep; 2018 Mar; 39(3):1516-1522. PubMed ID: 29328495
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
Jung SY; Rohan T; Strickler H; Bea J; Zhang ZF; Ho G; Crandall C
PLoS One; 2017; 12(10):e0186296. PubMed ID: 29023587
[TBL] [Abstract][Full Text] [Related]
9. Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway.
Wei H; Dong C; Shen Z
Neoplasma; 2020 Jul; 67(4):889-897. PubMed ID: 32386481
[TBL] [Abstract][Full Text] [Related]
10. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
[TBL] [Abstract][Full Text] [Related]
11. STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancer.
Wu F; Gao P; Wu W; Wang Z; Yang J; Di J; Jiang B; Su X
J Exp Clin Cancer Res; 2018 Jul; 37(1):144. PubMed ID: 29996891
[TBL] [Abstract][Full Text] [Related]
12. Altered liver expression of genes involved in lipid and glucose metabolism in mice with partial IGF-1 deficiency: an experimental approach to metabolic syndrome.
De Ita JR; Castilla-Cortázar I; Aguirre GA; Sánchez-Yago C; Santos-Ruiz MO; Guerra-Menéndez L; Martín-Estal I; García-Magariño M; Lara-Díaz VJ; Puche JE; Muñoz U
J Transl Med; 2015 Oct; 13():326. PubMed ID: 26467524
[TBL] [Abstract][Full Text] [Related]
13. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
14. Role of insulin-like growth factor-1R system in colorectal carcinogenesis.
Donovan EA; Kummar S
Crit Rev Oncol Hematol; 2008 May; 66(2):91-8. PubMed ID: 17977741
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
[TBL] [Abstract][Full Text] [Related]
16. Insulin/IGF-1 enhances intestinal epithelial crypt proliferation through PI3K/Akt, and not ERK signaling in obese humans.
Zhou W; Rowitz BM; Dailey MJ
Exp Biol Med (Maywood); 2018 Jul; 243(11):911-916. PubMed ID: 29950119
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
[TBL] [Abstract][Full Text] [Related]
18. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
[TBL] [Abstract][Full Text] [Related]
19. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor (IGF) axis in cancerogenesis.
Kasprzak A; Kwasniewski W; Adamek A; Gozdzicka-Jozefiak A
Mutat Res Rev Mutat Res; 2017; 772():78-104. PubMed ID: 28528692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
